XML 160 R111.htm IDEA: XBRL DOCUMENT v3.21.1

Share-Based Payments - Schedule of Number and Weighted-Average Exercise Price of Share Options Allocated and Expected to be Allocated (Details) - Management Board Grant	Dec. 31, 2022 shares € / shares	Dec. 31, 2021 shares € / shares	Dec. 31, 2020 shares € / shares	Feb. 13, 2020 shares € / shares
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Share options outstanding | shares			451,981
Weighted-average exercise price | € / shares			€ 45.89
Prof. Ugur Sahin, M.D.
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Share options outstanding | shares			101,686	97,420
Weighted-average exercise price | € / shares			€ 10.14	€ 28.32
Prof. Ugur Sahin, M.D. | Estimated Allocation Date 2021
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Share options outstanding | shares		39,826
Weighted-average exercise price | € / shares		€ 67.26
Prof. Ugur Sahin, M.D. | Estimated Allocation Date 2022
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Share options outstanding | shares	39,817
Weighted-average exercise price | € / shares	€ 67.27
Sean Marett
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Share options outstanding | shares			33,895	38,968
Weighted-average exercise price | € / shares			€ 10.14	€ 28.32
Sean Marett | Estimated Allocation Date 2021
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Share options outstanding | shares		15,930
Weighted-average exercise price | € / shares		€ 67.26
Sean Marett | Estimated Allocation Date 2022
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Share options outstanding | shares	15,927
Weighted-average exercise price | € / shares	€ 67.27
Dr. Sierk Poetting
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Share options outstanding | shares			33,895	38,968
Weighted-average exercise price | € / shares			€ 10.14	€ 28.32
Dr. Sierk Poetting | Estimated Allocation Date 2021
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Share options outstanding | shares		15,930
Weighted-average exercise price | € / shares		€ 67.26
Dr. Sierk Poetting | Estimated Allocation Date 2022
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Share options outstanding | shares	15,927
Weighted-average exercise price | € / shares	€ 67.27
Dr. Ozlem Tureci, M.D.
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Share options outstanding | shares			108,463	38,968
Weighted-average exercise price | € / shares			€ 10.14	€ 28.32
Dr. Ozlem Tureci, M.D. | Estimated Allocation Date 2021
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Share options outstanding | shares		15,930
Weighted-average exercise price | € / shares		€ 67.26
Dr. Ozlem Tureci, M.D. | Estimated Allocation Date 2022
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Share options outstanding | shares	15,927
Weighted-average exercise price | € / shares	€ 67.27
Ryan Richardson
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Share options outstanding | shares			8,306	33,772
Weighted-average exercise price | € / shares			€ 10.14	€ 28.32
Ryan Richardson | Estimated Allocation Date 2021
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Share options outstanding | shares		13,806
Weighted-average exercise price | € / shares		€ 67.26
Ryan Richardson | Estimated Allocation Date 2022
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Share options outstanding | shares	14,865
Weighted-average exercise price | € / shares	€ 67.27

X

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The number of share options outstanding in a share-based payment arrangement.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2020-01-01
-Paragraph 45
-Subparagraph d
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45_d&doctype=Standard
-URIDate 2020-01-01

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2020-01-01
-Paragraph 45
-Subparagraph b
-Clause i
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45_b_i&doctype=Standard
-URIDate 2020-01-01

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2020-01-01
-Paragraph 45
-Subparagraph b
-Clause vi
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45_b_vi&doctype=Standard
-URIDate 2020-01-01

+ Details

Name:	ifrs-full_NumberOfOutstandingShareOptions
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	instant

X

- Definition

The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2020-01-01
-Paragraph 45
-Subparagraph b
-Clause i
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45_b_i&doctype=Standard
-URIDate 2020-01-01

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2020-01-01
-Paragraph 45
-Subparagraph b
-Clause vi
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45_b_vi&doctype=Standard
-URIDate 2020-01-01

+ Details

Name:	ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
Namespace Prefix:	ifrs-full_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

X

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=bntx_ManagementBoardGrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_TitleOfIndividualAxis=bntx_ProfessorUgurSahinMDMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=bntx_EstimatedAllocationDateOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=bntx_EstimatedAllocationDateTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_TitleOfIndividualAxis=bntx_SeanMarettMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_TitleOfIndividualAxis=bntx_DrSierkPoettingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_TitleOfIndividualAxis=bntx_DrOzlemTureciMDMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_TitleOfIndividualAxis=bntx_RyanRichardsonMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: